Literature DB >> 27904140

Restrictions in the T-cell repertoire of chronic lymphocytic leukemia: high-throughput immunoprofiling supports selection by shared antigenic elements.

A Vardi1,2,3, E Vlachonikola1, M Karypidou1, E Stalika1, V Bikos4, K Gemenetzi1, C Maramis1,5, A Siorenta6, A Anagnostopoulos2, S Pospisilova4, N Maglaveras1,5, I Chouvarda1,5, K Stamatopoulos1,7, A Hadzidimitriou1,7.   

Abstract

Immunoglobulin (IG) gene repertoire restrictions strongly support antigen selection in the pathogenesis of chronic lymphocytic leukemia (CLL). Given the emerging multifarious interactions between CLL and bystander T cells, we sought to determine whether antigen(s) are also selecting T cells in CLL. We performed a large-scale, next-generation sequencing (NGS) study of the T-cell repertoire, focusing on major stereotyped subsets representing CLL subgroups with undisputed antigenic drive, but also included patients carrying non-subset IG rearrangements to seek for T-cell immunogenetic signatures ubiquitous in CLL. Considering the inherent limitations of NGS, we deployed bioinformatics algorithms for qualitative curation of T-cell receptor rearrangements, and included multiple types of controls. Overall, we document the clonal architecture of the T-cell repertoire in CLL. These T-cell clones persist and further expand overtime, and can be shared by different patients, most especially patients belonging to the same stereotyped subset. Notably, these shared clonotypes appear to be disease-specific, as they are found in neither public databases nor healthy controls. Altogether, these findings indicate that antigen drive likely underlies T-cell expansions in CLL and may be acting in a CLL subset-specific context. Whether these are the same antigens interacting with the malignant clone or tumor-derived antigens remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27904140     DOI: 10.1038/leu.2016.362

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  31 in total

1.  Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.

Authors:  Panagiotis Baliakas; Andreas Agathangelidis; Anastasia Hadzidimitriou; Lesley-Ann Sutton; Eva Minga; Athina Tsanousa; Lydia Scarfò; Zadie Davis; Xiao-Jie Yan; Tait Shanafelt; Karla Plevova; Yorick Sandberg; Fie Juhl Vojdeman; Myriam Boudjogra; Tatiana Tzenou; Maria Chatzouli; Charles C Chu; Silvio Veronese; Anne Gardiner; Larry Mansouri; Karin E Smedby; Lone Bredo Pedersen; Denis Moreno; Kirsten Van Lom; Véronique Giudicelli; Hana Skuhrova Francova; Florence Nguyen-Khac; Panagiotis Panagiotidis; Gunnar Juliusson; Lefteris Angelis; Achilles Anagnostopoulos; Marie-Paule Lefranc; Monica Facco; Livio Trentin; Mark Catherwood; Marco Montillo; Christian H Geisler; Anton W Langerak; Sarka Pospisilova; Nicholas Chiorazzi; David Oscier; Diane F Jelinek; Nikos Darzentas; Chrysoula Belessi; Frederic Davi; Paolo Ghia; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Blood       Date:  2014-12-17       Impact factor: 22.113

2.  The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia.

Authors:  Jennifer R Brown; Jacqueline C Barrientos; Paul M Barr; Ian W Flinn; Jan A Burger; Anh Tran; Fong Clow; Danelle F James; Thorsten Graef; Jonathan W Friedberg; Kanti Rai; Susan O'Brien
Journal:  Blood       Date:  2015-03-09       Impact factor: 22.113

3.  Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin.

Authors:  Charles C Chu; Rosa Catera; Lu Zhang; Sebastien Didier; Briana M Agagnina; Rajendra N Damle; Matthew S Kaufman; Jonathan E Kolitz; Steven L Allen; Kanti R Rai; Nicholas Chiorazzi
Journal:  Blood       Date:  2010-01-28       Impact factor: 22.113

4.  Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.

Authors:  Gerard Tobin; Ulf Thunberg; Anna Johnson; Inger Eriksson; Ola Söderberg; Karin Karlsson; Mats Merup; Gunnar Juliusson; Juhani Vilpo; Gunilla Enblad; Christer Sundström; Göran Roos; Richard Rosenquist
Journal:  Blood       Date:  2003-02-13       Impact factor: 22.113

5.  Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer.

Authors:  Alan G Ramsay; Andrew J Clear; Rewas Fatah; John G Gribben
Journal:  Blood       Date:  2012-04-30       Impact factor: 22.113

6.  Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis.

Authors:  Fiona Murray; Nikos Darzentas; Anastasia Hadzidimitriou; Gerard Tobin; Myriam Boudjogra; Cristina Scielzo; Nikolaos Laoutaris; Karin Karlsson; Fanny Baran-Marzsak; Athanasios Tsaftaris; Carol Moreno; Achilles Anagnostopoulos; Federico Caligaris-Cappio; Dominique Vaur; Christos Ouzounis; Chrysoula Belessi; Paolo Ghia; Fred Davi; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Blood       Date:  2007-10-24       Impact factor: 22.113

7.  Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen.

Authors:  Lesley-Ann Sutton; Efterpi Kostareli; Anastasia Hadzidimitriou; Nikos Darzentas; Athanasios Tsaftaris; Achilles Anagnostopoulos; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Blood       Date:  2009-08-27       Impact factor: 22.113

8.  Antigen Selection Shapes the T-cell Repertoire in Chronic Lymphocytic Leukemia.

Authors:  Anna Vardi; Andreas Agathangelidis; Evangelia Stalika; Maria Karypidou; Alexandra Siorenta; Achilles Anagnostopoulos; Richard Rosenquist; Anastasia Hadzidimitriou; Paolo Ghia; Lesley-Ann Sutton; Kostas Stamatopoulos
Journal:  Clin Cancer Res       Date:  2015-09-02       Impact factor: 12.531

9.  Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug.

Authors:  Alan G Ramsay; Amy J Johnson; Abigail M Lee; Güllü Gorgün; Rifca Le Dieu; William Blum; John C Byrd; John G Gribben
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

10.  Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.

Authors:  John C Byrd; Richard R Furman; Steven E Coutre; Ian W Flinn; Jan A Burger; Kristie A Blum; Barbara Grant; Jeff P Sharman; Morton Coleman; William G Wierda; Jeffrey A Jones; Weiqiang Zhao; Nyla A Heerema; Amy J Johnson; Juthamas Sukbuntherng; Betty Y Chang; Fong Clow; Eric Hedrick; Joseph J Buggy; Danelle F James; Susan O'Brien
Journal:  N Engl J Med       Date:  2013-06-19       Impact factor: 91.245

View more
  21 in total

Review 1.  Emerging role of BCR signaling inhibitors in immunomodulation of chronic lymphocytic leukemia.

Authors:  Kamira Maharaj; Eva Sahakian; Javier Pinilla-Ibarz
Journal:  Blood Adv       Date:  2017-09-26

2.  Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL.

Authors:  Gonzalo Blanco; Anna Vardi; Anna Puiggros; Andrea Gómez-Llonín; Manuel Muro; María Rodríguez-Rivera; Evangelia Stalika; Eugenia Abella; Eva Gimeno; Manuela López-Sánchez; Alicia Senín; Xavier Calvo; Pau Abrisqueta; Francesc Bosch; Ana Ferrer; Kostas Stamatopoulos; Blanca Espinet
Journal:  Oncoimmunology       Date:  2018-02-20       Impact factor: 8.110

3.  Activation and expansion of T-follicular helper cells in chronic lymphocytic leukemia nurselike cell co-cultures.

Authors:  Alicia M Vaca; Nikolaos Ioannou; Mariela Sivina; Elisavet Vlachonikola; Karen Clise-Dwyer; Ekaterina Kim; Dan Li; Qing Ma; Alessandra Ferrajoli; Zeev Estrov; William G Wierda; Piers E M Patten; Alan G Ramsay; Jan A Burger
Journal:  Leukemia       Date:  2022-02-11       Impact factor: 11.528

Review 4.  In Vitro and In Vivo Models of CLL-T Cell Interactions: Implications for Drug Testing.

Authors:  Eva Hoferkova; Sona Kadakova; Marek Mraz
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

5.  Control of chronic lymphocytic leukemia development by clonally-expanded CD8+ T-cells that undergo functional exhaustion in secondary lymphoid tissues.

Authors:  Bola S Hanna; Philipp M Roessner; Haniyeh Yazdanparast; Dolors Colomer; Elias Campo; Sabrina Kugler; Deyan Yosifov; Stephan Stilgenbauer; Manfred Schmidt; Richard Gabriel; Peter Lichter; Martina Seiffert
Journal:  Leukemia       Date:  2018-09-28       Impact factor: 11.528

6.  Select Antitumor Cytotoxic CD8+ T Clonotypes Expand in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.

Authors:  Maria Joao Baptista; Sivasubramanian Baskar; Erika M Gaglione; Keyvan Keyvanfar; Inhye E Ahn; Adrian Wiestner; Clare Sun
Journal:  Clin Cancer Res       Date:  2021-04-19       Impact factor: 13.801

7.  Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia.

Authors:  Gonzalo Blanco; Anna Puiggros; Barbara Sherry; Lara Nonell; Xavier Calvo; Eulàlia Puigdecanet; Pui Yan Chiu; Yasmine Kieso; Gerardo Ferrer; Florencia Palacios; Magdalena Arnal; María Rodríguez-Rivera; Eva Gimeno; Eugènia Abella; Kanti R Rai; Pau Abrisqueta; Francesc Bosch; Alexandre Calon; Ana Ferrer; Nicholas Chiorazzi; Blanca Espinet
Journal:  Exp Hematol       Date:  2021-01-07       Impact factor: 3.249

8.  Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells.

Authors:  Parviz Kokhaei; Mohammad Hojjat-Farsangi; Fariba Mozaffari; Ali Moshfegh; Fatemeh Pak; Ali Rashidy-Pour; Marzia Palma; Lotta Hansson; Anders Österborg; Håkan Mellstedt
Journal:  PLoS One       Date:  2018-02-12       Impact factor: 3.240

9.  CD4+ T cells sustain aggressive chronic lymphocytic leukemia in Eμ-TCL1 mice through a CD40L-independent mechanism.

Authors:  Matteo Grioni; Arianna Brevi; Elena Cattaneo; Alessandra Rovida; Jessica Bordini; Maria Teresa Sabrina Bertilaccio; Maurilio Ponzoni; Giulia Casorati; Paolo Dellabona; Paolo Ghia; Matteo Bellone; Arianna Calcinotto
Journal:  Blood Adv       Date:  2021-07-27

10.  T cells in chronic lymphocytic leukemia: can they fight?

Authors:  Anna Vardi; Kostas Stamatopoulos; Anastasia Hadzidimitriou
Journal:  Oncotarget       Date:  2017-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.